[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100260872":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":10,"locations":27,"responsibleParty":63,"collaborators":10,"id":65,"slug":66,"hasResults":67,"nctId":68,"briefTitle":69,"officialTitle":70,"acronym":71,"eligibilityCriteria":72,"healthyVolunteers":67,"sex":73,"minAge":74,"maxAge":10,"enrollmentInfo":75,"targetDuration":10,"studyType":78,"phases":10,"briefSummary":79,"conditions":80,"keywords":84,"overallStatus":90,"whyStopped":10,"lastUpdateSubmitDate":91,"lastUpdatePostDateStruct":92,"startDateStruct":94,"completionDateStruct":96,"leadSponsor":98,"locationsCount":99},{"fullName":5,"class":6},"Centre Hospitalier Universitaire de Saint Etienne","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Pediatric cancer young adult survivors",null,"544 patients alive and that are min 18 years old, included in the ARCERRA population register, for a primary cancer (not leukemia), diagnosed between 15 years old, between January the 1st 1993, and December the 31st 1999, in Rhône-Alpes.",[13],"Other: Pediatric cancer young adult survivors",[15],{"type":6,"name":9,"description":16,"armGroupLabels":17,"otherNames":18},"Patients will receive a questionnaire, a consultation with an oncologist and a psychologist will be planned, and two years later, patients will have to answer again to the questionnaire.",[9],[19],"Long term follow up",[21,24],{"name":22,"affiliation":5,"role":23},"BERGER Claire, MD","PRINCIPAL_INVESTIGATOR",{"name":25,"affiliation":5,"role":26},"Léonie CASAGRANDA, PhD","STUDY_CHAIR",[28,40,49,54],{"facility":29,"status":10,"city":30,"state":10,"zip":31,"country":32,"countryCode":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":10},"Chu Grenoble","Grenoble","38000","France","FR",{"type":35,"coordinates":36},"Point",[37,38],5.71479,45.17869,{"lat":38,"lon":37},{"facility":41,"status":10,"city":42,"state":10,"zip":43,"country":32,"countryCode":33,"cosmosGeoPoint":44,"geoPoint":48,"contacts":10},"IHOP1 de Lyon","Lyon","69000",{"type":35,"coordinates":45},[46,47],4.84789,45.74906,{"lat":47,"lon":46},{"facility":50,"status":10,"city":42,"state":10,"zip":10,"country":32,"countryCode":33,"cosmosGeoPoint":51,"geoPoint":53,"contacts":10},"CH Lyon Sud - Pierre Bénite",{"type":35,"coordinates":52},[46,47],{"lat":47,"lon":46},{"facility":55,"status":10,"city":56,"state":10,"zip":57,"country":32,"countryCode":33,"cosmosGeoPoint":58,"geoPoint":62,"contacts":10},"Chu Saint Etienne","Saint-Etienne","42100",{"type":35,"coordinates":59},[60,61],4.39,45.43389,{"lat":61,"lon":60},{"type":64,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100260872","getting-long-term-management-of-adult-children-cured-of-childhood-cancer-in-rhne-alpes-100260872",false,"NCT02675166","Getting Long-term Management of Adult Children Cured of Childhood Cancer in Rhône-Alpes","SALTO -2 ( Long Term Monitoring In Oncology ) : Getting Long-term Management of Adult Children Cured of Childhood Cancer in Rhône-Alpes, Multicentric Study","SALTO-2","Inclusion Criteria:\n\n* Had a cancer diagnostic between January the 1st 1993 and December the 31st 1999, before the age of 15 years old, in Rhône-Alpes\n* Being a beneficiary of health insurance\n* Having signed the informed consent form\n\nExclusion Criteria:\n\n* Having been diagnosed with leukemia as a primary cancer","ALL","18 Years",{"count":76,"type":77},137,"ACTUAL","OBSERVATIONAL","Children cancers are rare and survival rate are around 75%. 1 French adult out of 850 is estimated as a children-cancer-survivor. Chemotherapy, radiotherapy or surgical complications can lead to a late risk of death. A regularly support, a therapeutic education, a support of the psychological difficulties have a positive impact on the quality of life and on long-term health for patients surviving to a cancer.\n\nThe ARCERRA exists, registering around 150 new cases a year. They coordinated, from 2011 to 2014, a multicentric study with a long term follow up in oncology (SALTO). 150 patients diagnosed between 1987 and 1992 were included, and the study demonstrated the feasibility and utility for patients and their physicians of a long-term follow-up coupled with an interview with a psychologist in Rhône-Alpes-Auvergne.\n\nThe primary objective of SALTO-2 project is to know the becoming of young adults that survived to pediatric cancer, diagnosed in Rhône-Alpes between 1993 and 1999. The second objective is in one hand to study the psychological becoming and on another hand, to ameliorate their lifestyle thanks to different documents created specially for them.",[81,82,83],"Pediatric Cancer","Sequels","Complications",[85,82,83,86,87,88,89],"Childhood cancer","Surgery","Radiotherapy","Chemotherapy","Cancer","COMPLETED","2018-10-19",{"date":93,"type":77},"2018-10-22",{"date":95,"type":77},"2015-10-23",{"date":97,"type":77},"2018-03-01",{"name":5,"class":6},4]